OlympiA 10 Year Follow Up
OlympiA: 10-Yr Follow-up With Adjuvant Olaparib in Patients With gBRCA1/2-Mutated HER2-Negative Early Breast Cancer

Released: December 18, 2024

Expiration: June 17, 2025

Activity

Progress
1
Course Completed